The mass spectrometry-based test measures homocysteine levels in newborns to detect the metabolic disease homocystinuria.
Ibex announced earlier this month that it had secured several contracts to offer Galen Prostate and Galen Breast to 25 UK National Health Service trusts.
The company's next-generation sequencing-based test detects more than 400 recurrent alterations that can identify 96 percent of bladder cancers.
White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development
The report, on goals for biotechnology and biomanufacturing in the US, suggests areas of investment including multiomics, cell therapies, gene editing, and microbial genome sequencing.
Thermo Fisher Scientific's IonTorrent Genexus platform can provide cancer panel results in about a day, but data on clinical impact of the fast turnaround has not yet been produced.